Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Relmada Therapeutics Inc (NQ: RLMD )

36.99 -0.62 (-1.66%)
Streaming Delayed Price Updated: 12:33 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,464
Open 37.39
Bid (Size) 36.65 (1)
Ask (Size) 37.50 (1)
Prev. Close 37.62
Today's Range 36.15 - 38.21
52wk Range 23.25 - 54.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Relmada Therapeutics Announces Initiation of Phase 3 Program for REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that the first patient has been enrolled in the... 
From PR Newswire
Relmada Therapeutics to Participate in Upcoming Investor Conferences
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Sergio Traversa, Chief... 
From PR Newswire

Performance

YTD
+12.17%
+12.17%
1 Month
+4.65%
+4.65%
3 Month
+4.51%
+4.51%
6 Month
-7.93%
-7.93%
1 Year
-4.60%
-4.60%

More News

Read More
On the Trail of Better Therapeutics for Depression
From PR Newswire
Relmada Therapeutics Expands R&D Team, Appoints Paolo Manfredi, M.D., as Acting Chief Scientific Officer, Marco Pappagallo, M.D., as Acting Chief Medical Officer and Updates R&D Milestones
From PR Newswire
On the Trail of Better Therapeutics for Depression
From InvestorBrandNetwork
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Relmada Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
From PR Newswire
Analysts Anticipate XPH Will Reach $67
Tags ETFs
From ETF Channel
Relmada Therapeutics (RLMD) Shares Cross Above 200 DMA
Tags Stocks
From Market News Video
Notable Monday Option Activity: PINS, RLMD, LCUT
Tags Stocks
From Market News Video
How The Pieces Add Up: XPH Headed For $65
Tags ETFs
From ETF Channel
VistaGen Is Prepared For 2021 Fueled By Recent Analyst Upgrades And Large Institutional Buyers
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
#